Zhejiang Tailin BioEngineering Co.,Ltd

Equities

300813

CNE100003S89

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 06:00:00 2024-07-04 pm EDT 5-day change 1st Jan Change
16.67 CNY +3.54% Intraday chart for Zhejiang Tailin BioEngineering Co.,Ltd -1.48% -32.01%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhejiang Tailin Bioengineering Co.,Ltd Announces Final Dividend Implementation Per A Shares for the Year 2023, Payable on 27 May 2024 CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2023 CI
Zhejiang Tailin BioEngineering Co.,Ltd Announces Management Appointments CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for 2023 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 11 May 2023 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Tailin Bioengineering Co.,Ltd. Proposes Final Cash Dividend for 2022 CI
Certain A Shares of Zhejiang Tailin BioEngineering Co.,Ltd are subject to a Lock-Up Agreement Ending on 15-JAN-2023. CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Tailin Medical Engineering Co., Ltd. announced that it has received CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves the Final Cash Dividend for the Year 2021, Payable on May 18, 2022 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Cash Dividend for the Year of 2021 CI
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhejiang Tailin Life Science Co., Ltd. announced that it expects to receive CNY 40 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd CI
Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds MT
Zhejiang Tailin BioEngineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Zhejiang Tailin Bioengineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhejiang Tailin Bioengineering Co.,Ltd Approves Cash Dividend for the Year 2020, Payable on May 26 , 2021 CI
Zhejiang Tailin BioEngineering Co.,Ltd Proposes Final Dividend for 2020 CI
Chart Zhejiang Tailin BioEngineering Co.,Ltd
More charts
Zhejiang Tailin Bioengineering Co Ltd is a China-based company mainly engaged in the research, development, production and promotion of products such as microbial detection and contamination control, innovative drug research and development and production, process analysis and containment protection in the field of life sciences. The Company's microbial detection technology product series includes bacteria collectors, bacteria collectors, microbial testers and others. The Company's aseptic production and contamination control equipment series includes isolators, aseptic transfer chambers and containment isolators and others. The Company's organic monitoring and analysis instrument series includes solid combustion devices, biodegradation test systems and headspace oxygen analyzers and others. The Company's products are used in industries such as biopharmaceuticals, medical and health care, experimental animal research, food safety, water quality monitoring and environmental protection.
More about the company
  1. Stock Market
  2. Equities
  3. 300813 Stock
  4. News Zhejiang Tailin BioEngineering Co.,Ltd
  5. Zhejiang Tailin Bioengineering Sells $33 Million RMB Convertible Bonds